Search
for
Sort by
Research 541–570 of 1000+
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Evaluation of COVID-19 risk in patients on systemic retinoid therapy
- The impact of COVID-19 pandemic and lockdown on chronic stress assessed by hair cortisol analysis via LC-MS/MS
- Síndrome Pós-Covid-19: Manejo nutricional das principais alterações
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Skin disorders associated with the COVID‐19 pandemic: A review
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Discovering the potential of natural remedies in the post COVID-19 complications based on in silico techniques
- A Retrospective Analysis from Turkey: The Effect of the COVID-19 Outbreak Quarantine on Dermatology Outpatient Clinics
- Dermatological manifestations of Coronavirus Disease 2019 (COVID-19)
- Study of Paediatric Dermatology Consultations during COVID-19 Lockdown
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- Androgen deprivation therapy and hormonal status in men with COVID-19
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Heterogeneous red–white discoloration of the nail bed and distal onycholysis in a patient with COVID‐19
- 067 BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series